1 February 2024 in Journal of Plastic, Reconstructive & Aesthetic Surgery
6 January 2026 in Journal of Craniofacial Surgery
Background: Vascularized composite allotransplantation (VCA) represents a transformative advance in reconstructive surgery, offering restoration of essential functions and psychological well-being for individuals with severe facial trauma or anomalies. There are different types of VCA. Facial vascularized composite allotransplantation (FVCA) is a complex procedure that carries the potential risk of severe complications in the event of rejection. There is a paucity of research that compares outcomes following FVCA to other types of VCA. Methods: Data were retrieved from the Organ Procurement and Transplantation Network (OPTN) database, which provides comprehensive information on all US organ donation and transplant activities. A search identified 96 eligible VCA cases, consisting of 16 FVCAs and 80 non-FVCA cases that were included in the final analysis. Results: In facial vascularized composite allotransplantation (FVCA) recipients, the median number of acute rejection episodes was significantly higher compared with non-FVCA patients [5.0 (IQR=0.0–10) versus 0.0 (IQR=0.0–2.0), P =0.0022]. Similarly, the median number of hospitalizations was greater in FVCA patients [3.0 (IQR=0.75–4.0) versus 0.0 (IQR=0.0–1.0), P <0.001]. While the overall complication rates did not differ significantly between groups (44% versus 25%, P =0.14), infectious complications were notably more frequent in FVCA recipients (44% versus 15%, P =0.015). Conclusion: Facial vascularized composite allotransplantation (FVCA) stands out from VCA procedures due to its heightened immunologic complexity and unique clinical challenges, including high antigenicity from the included skin, presensitized patients, and visible grafts. Facial vascularized composite allotransplantation (FVCA) demands stronger immunosuppression and intensive perioperative monitoring to manage complications. Continued efforts to optimize these strategies are crucial to reduce morbidity and improve outcomes, ensuring FVCA’s transformative potential is realized safely and effectively.
13 July 2026 in Journal of Craniofacial Surgery
Background: The Le Fort I osteotomy is a standard approach for treating the maxilla in orthognathic surgery. Achieving stable ossification, particularly in cases requiring significant movements, can be clinically challenging and may compromise the ossification process. Despite the clinical significance of this issue, there remains a lack of robust multicenter studies directly comparing outcomes of Le Fort I osteotomies performed with versus without bone grafting (BG). Methods: In this study, the authors accessed the ACS-NSQIP database from 2008 to 2023 to identify patients who underwent isolated surgical Le Fort I osteotomy with and without BG. Collected data included demographics, comorbidities, surgical characteristics, and 30-day postoperative outcomes. Results: Of 418 patients who underwent an isolated Le Fort I osteotomy, 95 patients (22.7%) underwent augmentation of the gap using BG, while 323 patients (77.3%) underwent surgery without BG. Overall, 13 (4.0%) non-BG and 7 (7.4%) BG patients experienced any complication ( P =0.88). In a multivariable analysis of all study cases, longer hospital stays ( P <0.01) were identified as an independent risk factor for the occurrence of any postoperative complications, whereas higher BMI ( P =0.02) and obesity ( P =0.04) were found to be independent risk factors for the occurrence of surgical complications. Conclusion: The Le Fort I osteotomy is an overall safe procedure. In this study, the use of BG did not appear to increase the risk of postoperative complications compared with procedures performed without BG. Identified risk factors for postoperative complications are prolonged hospital stays, higher BMI, and obesity.
20 May 2026 in JPRAS Open
Reliable perfusion of the distal portion of free parascapular (PSC) flaps is essential for successful lower extremity reconstruction. We hypothesized that intraoperative indocyanine green near-infrared video angiography (ICG-NIR-VA) enables reliable assessment of distal flap perfusion, thereby supporting microsurgical decision-making and reducing the risk of distal flap necrosis. We conducted a retrospective analysis of all free parascapular (PSC) flaps performed for lower extremity reconstruction between January 2015 and December 2024. Patients were non-randomly assigned to intraoperative perfusion assessment using indocyanine green near-infrared video angiography (ICG-NIR-VA; study group, n = 45) or conventional clinical evaluation (control group, n = 67). In both groups, inadequately perfused flap segments were trimmed intraoperatively at the surgeon’s discretion. Primary endpoints were distal or total flap necrosis, while secondary outcomes included reoperation rates and postoperative length of hospital stay (POLHS. Intraoperative use of ICG-NIR-VA guided PSC flap design by identifying poorly perfused distal flap portions in 15 of 45 cases (33%), all of which resulted in uncomplicated postoperative courses. Partial flap necrosis occurred in 3 of 45 flaps (6.7%) in the ICG-NIR-VA group compared to 12 of 67 flaps (18.0%) in the control group (p = 0.09). Overall, intraoperative ICG-NIR-VA showed a strong correlation with postoperative outcomes, reflected by a negative predictive value of 98%. Furthermore, ICG-NIR-VA–assisted reconstructions required fewer recipient-site revision surgeries (9/45 [20.0%] vs. 24/67 [35.8%], p = 0.10) and showed a non-significant trend toward a shorter postoperative length of hospital stay (19 ± 10 vs. 21 ± 11 days, p = 0.40). Our findings suggest that ICG-NIR-VA may support intraoperative decision-making and may be associated with improved clinical outcomes, although several observed differences did not reach statistical significance.